Course Director

• Agata Rembielak, Radiation Oncologist and Clinical Oncologist, The Christie Hospital and The University of Manchester, Manchester (UK)

Teachers

• Alessandro Di Stefani, Dermatologist and Dermatopathologist, Università Cattolica del Sacro Cuore, Rome (IT)

• Damir Kosutic, Plastic and Reconstructive Surgeon, The Christie Hospital, Manchester (UK)

• Anita O’Donovan, Radiographer with research interest in geriatric oncology, Trinity College, Dublin (IE)

• Susy Pramod, Tissue Viability Nurse, The Christie Hospital, Manchester (UK)

  • Luca Tagliaferri, Radiation Oncologist, Fondazione Policlinico Universitario «Agostino Gemelli» IRCCS,        Rome (IT)

• Anysja Zuchora, Medical Physicist, Galway University Hospital, Galway (IE)

• Laure Marignol, Radiation Biologist, Trinity College, Dublin (IE)

Local Organiser

Piotr Wojcieszek, Radiation Oncologist, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice (PL)

This course aims to bring various specialists and trainees in the field of dermato-oncology in order to breach gaps between specializations, increase multidisciplinary understanding and highlight the need for improved interdisciplinary collaboration. The faculty includes renowned experts involved in the multidisciplinary treatment of NMSC. It is hoped that the course will serve a vital reference for all professionals involved in the management of NMSC.

Learning outcomes

The course will be interactive through integration of multidisciplinary lectures and more focused debates and case discussions. By the end of this course participants should be able to:

• Understand prophylaxis, epidemiology and pathology of NMSC with special focus on basal, cutaneous squamous and Merkel cell carcinoma. Rare skin cancers will also be included.

• Discuss advantages and limitations of imaging modalities used for diagnosis and treatment of NMSC

• Understand indications and limitations of surgical and non-surgical treatment modalities in NMSC

• Design a radical and palliative radiotherapy plan for NMSC

• Develop a deep understanding of best practices in NMSC and provide patients with the best possible treatment, skin care advice and follow-up care

• Understand challenges of palliative and supportive care in NMSC patients

• Have a general understanding of principles in geriatric oncology and integrate geriatric oncology assessment into clinical practice patients with NMSC

• Summarise the latest developments and gain knowledge of future directions in research and clinical trials in the management of NMSC.

Course content

• Epidemiology, prevention, pathology and biomarkers of NMSC

• The role of imaging in diagnosis and treatment of NMSC

• Surgical and non-surgical treatments of NMSC

• Physics and mould room input in dermatological radiotherapy and brachytherapy

• Radiobiology of the skin and skin cancer

• Follow-up and management of side effects during and after skin cancer treatment

• Role of allied health care professionals in NMSC management

• Concept and management of high risk, locally advanced and metastatic NMSC 

• NMSC in special circumstances and rare skin pathologies

• Role of multidisciplinary team meetings in the management of NMSC

• Overview of current research, clinical trials and technical developments in the management of NMSC.

Prerequisites

Before commencing this course participants should:

• Revise anatomy and histology of the skin and lymphatic system with common drainage routes

• Have at least basic knowledge of main NMSC types and their clinical presentation

• Have at least basic knowledge of standard surgical and non-surgical treatment modalities in NMSC

• Have at least basic experience with radiation therapy in patients with NMSC. If the participant is not a radiation oncologist or clinical oncologist (including training post) they should be involved in multidisciplinary case discussions or have special interest in the management of patients with NMSC

• Be prepared to ask questions and contribute to live and interactive discussions.

Teaching methods

The course is delivered face-to-face over two and a half days and will include:

• Prerequisite course materials

• Didactic lectures

• Debates and case discussions

Students will be advised to review the prerequisite course materials and suggested readings on ESTRO Moodle before the course. The prerequisite materials and live lectures create a complete subject unit.

Methods of assessment

• Mark-out exercises

• Evaluation form

Key words

Non-melanoma skin cancer, multimodality management, surgery, radiotherapy, systemic treatment, high risk non-melanoma skin cancer, volume delineation, side effects, cosmesis, quality of life, geriatric assessment.

Accreditation

Application for CME recognition will be submitted to the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician’s Recognition Award (PRA). Information on the status of the applications can be obtained from the ESTRO office.

Novotel Kraków Centrum, ul. Tadeusza Kościuszki 5, 30-105, Krakow, Poland

A final programme is available here.

Membership

ESTRO members can order products at substantially reduced prices. To benefit from the member registration rate, you must subscribe for the ESTRO membership 2024 BEFORE registering to the course. To become an ESTRO member, benefit from the member registration rate and discover the many other member advantages, please visit the membership page.

Fees

* Members with specialty RadiationTherapist (RTT) may register at the In-Training fee

Early rates are applied up to three months before the starting date of the course.

Late rates are applied three months before the starting date of the course.

The fee includes the course material, coffees, lunches, and the social event.

Advance registration & payment are required.

Access to homework and/or course material will become available upon receipt of full payment.

Insurance and cancellation

Participants are strongly advised to take out their own personal insurance policy. ESTRO does not accept liability for individual medical, travel or personal accidents or incidents. Participants are strongly advised to take insurance policies to cover flight and accommodation cancellation penalties. ESTRO will not refund any travel or accommodation expenses.

For any cancellation made by the course or workshop participant, ESTRO School Events Cancellation Policy will be followed and all stated penalty fees will be applied. 

Reduced fees

Members from emerging countries may register at a preferential rate of 350 Euro. Emerging country fee applies to individuals from low-income and lower-middle-income economies according to the World Bank listing here.

Additionally, for this teaching course, all specialties from the following countries can benefit from this preferential rate: Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Hungary, Macedonia, Moldova, Montenegro, Romania, Russian Federation, Serbia, Turkey, Ukraine. 

The preferential rate of 350 Euro is granted automatically when you click on the  BOOK NOW  button and the conditions below are met:

1. Only ESTRO members for 2024 are eligible (please make sure your 2024 membership is in order before you click on the BOOK NOW button)
2. The application is submitted 3 months before the course start date.
3. Only one course per person per year can be subsidized by ESTRO
4. Sponsored candidates are not entitled to reduced fees (the invoicing address has to be the one of the participant)  
5. There are limited spaces available for each course in the price category. Places are granted on “first come first serve” basis.